Your browser doesn't support javascript.
loading
Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use.
Luethi, Dino; Hoener, Marius C; Krähenbühl, Stephan; Liechti, Matthias E; Duthaler, Urs.
Afiliación
  • Luethi D; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Hoener MC; Neuroscience Research, pRED, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Krähenbühl S; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Liechti ME; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland. Electronic address: matthias.liechti@usb.ch.
  • Duthaler U; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
Biochem Pharmacol ; 164: 129-138, 2019 06.
Article en En | MEDLINE | ID: mdl-30981875

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Microsomas Hepáticos / Agonistas de Receptores de Serotonina / Sistema Enzimático del Citocromo P-450 / Dietilamida del Ácido Lisérgico Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Biochem Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Microsomas Hepáticos / Agonistas de Receptores de Serotonina / Sistema Enzimático del Citocromo P-450 / Dietilamida del Ácido Lisérgico Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Biochem Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Suiza